EDMONTON, Alberta — Isotechnika Pharma Inc. ("Isotechnika" or the "Company") announced today that, further to its press release of November 14, 2012, a Partial Award in the Company's …

Pharmaceutical Market Fails to Capture $188 Billion U.S. Revenue and $564 Billion Global Revenue Annually Due to Medication Non-Adherence

Rheumatoid arthritis, a chronic inflammatory disease that causes pain, swelling and loss of joint function, is said to affect an estimated 1.3 million Americans. Developing a new drug for rheumatoid arthritis, designed for use in early stages of the di…

Declan Mur phy has liv ed a life of quiet service to others.

HORSHOLM, Denmark, Nov. 14, 2012 /PRNewswire/ –Highlights:Veloxis has in October 2012 entered into an exclusive distribution agreement with Chiesi Farmaceutici S.p.A, a fully integrated European Pharmaceutical …

EDMONTON, Alberta — Isotechnika Pharma Inc. today announced financial results for the third quarter ended September 30, 2012.

Is Vical in Romneyland?

NEW YORK — Intercept Pharmaceuticals, Inc. (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver diseases, …

Novartis Reveal Positive Results From Phase III Study In Liver Transplantation

The role of the new — and contentious — National Center for Advancing Translational Sciences is to " develop, demonstrate, and then disseminate improvements" to the process of translating basic findings to the clinic, NCATS chief Chris Au…